Teriparatide Therapy for Denosumab-Induced Osteonecrosis of the Jaw in a Male Osteoporotic Patient

被引：0
|
作者：
Audrey Neuprez
E. Rompen
J. M. Crielaard
Jean-Yves Reginster
机构：
[1] University of Liège,Belgium and Bone and Cartilage Metabolism Unit, Department of Public Health, Epidemiology and Health Economics
[2] CHU,Stomatology Department
[3] CHU,Motricity Sciences Department
[4] CHU,undefined
来源：
Calcified Tissue International | 2014年 / 95卷
关键词：
Denosumab; Osteonecrosis; Teriparatide; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We report the first case of teriparatide adjuvant role in the management of a denosumab-induced osteonecrosis of the jaw in a male subject with idiopathic osteoporosis. Clinical benefits and CT healing were obtained within 2 months of teriparatide initiation and denosumab withdrawal. Increase in bone turnover previously described, when denosumab treatment is removed, might have a synergistic effect to the stimulating effect of teriparatide on bone remodeling to promptly heal osteonecrosis of the jaw.
引用
收藏
页码：94 / 96
页数：2
相关论文
共 50 条
  • [1] Teriparatide Therapy for Denosumab-Induced Osteonecrosis of the Jaw in a Male Osteoporotic Patient
    Neuprez, Audrey
    Rompen, E.
    Crielaard, J. M.
    Reginster, Jean-Yves
    CALCIFIED TISSUE INTERNATIONAL, 2014, 95 (01) : 94 - 96
  • [2] Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
    Neuprez, A.
    Coste, S.
    Rompen, E.
    Crielaard, J. M.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) : 393 - 395
  • [3] Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
    A. Neuprez
    S. Coste
    E. Rompen
    J. M. Crielaard
    J. Y. Reginster
    Osteoporosis International, 2014, 25 : 393 - 395
  • [4] Osteonecrosis of the jaw in patient with denosumab therapy
    Olate, Sergio
    Uribe, Francisca
    Martinez, Felipe
    Almeida, Andres
    Unibazo, Alejandro
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (10): : 3707 - 3709
  • [5] Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw
    Bacian Martinez, Sandra
    Navarro Cuellar, Carlos
    Navarro Vila, Carlos
    Palacios Weiss, Edurne
    Pujol Romanya, Roser
    Fernandez de Velasco, Alvaro del Amo
    Escrig de Teijeiro, Margarita
    del Castillo Pardo de Vera, Jose Luis
    Rodriguez Perez, Irene
    Sanchez-Perez, Arturo
    Zamorano-Leon, Jose J.
    Lopez-Farre, Antonio
    Garcia-Hidalgo Alonso, Maria Isabel
    Navarro Cuellar, Ignacio
    APPLIED SCIENCES-BASEL, 2021, 11 (16):
  • [6] Teriparatide Therapy for Osteonecrosis of the Jaw
    Chtioui, Haithem
    Lamine, Faiza
    Daghfous, Riadh
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1081 - 1082
  • [7] Osteonecrosis of the Jaw in a Patient on Denosumab
    Aghaloo, Tara L.
    Felsenfeld, Alan L.
    Tetradis, Sotirios
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (05) : 959 - 963
  • [8] Teriparatide Therapy for Osteonecrosis of the Jaw REPLY
    Cheung, Ada
    Seeman, Ego
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1082 - 1082
  • [9] Denosumab-induced osteonecrosis of external auditory canal
    Takeda, Takamori
    Ito, Taku
    Onishi, Iichiroh
    Yokomura, Masaru
    Kawashima, Yoshiyuki
    Fujikawa, Taro
    Tsutsumi, Takeshi
    AURIS NASUS LARYNX, 2021, 48 (06) : 1199 - 1203
  • [10] Denosumab-Related Osteonecrosis of the Jaw May Not Be a Subject of Teriparatide Treatment
    Park, Kyung-Su
    Jung, Seung Min
    Park, Yune-Jung
    Kim, Ki-Jo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (10) : 2044 - 2045
12345